Even if they’re not acquired, these small companies are developing promising obesity and diabetes treatments.
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.
Read Next
- Draft Trump order would make sweeping State Department changes
- 7 habits of people who create connection in every conversation
- Trump ‘flouting the courts’ in Abrego Garcia case
- Yen, Brazilian Real, 5-Year Bonds & WTI Crude Oil lead Weekly Positions :: InvestMacro
- Vance to visit India for bilateral talks on trade and economic ties
- FX week in review: Scope and IC Markets MENA heads, Crypto exchanges adding traditional trading
- 7 things confident people never feel the need to explain
